Yo Nam Jang
Papers
1
Total Citations
32
H-Index
1
About
Dr. Yo Nam Jang is an anesthesiologist and clinical researcher whose work centers on optimizing perioperative care and recovery outcomes. Her primary research areas include anesthetic pharmacology, quality of recovery metrics, and the comparative effectiveness of novel sedative agents. Dr. Jang is best known for her landmark 2022 randomized controlled trial comparing remimazolam—a novel, ultra-short-acting benzodiazepine—to traditional inhalant anesthetics for maintenance of general anesthesia. This study, which has garnered 32 citations, provided the first rigorous evidence that remimazolam may enhance early postoperative recovery quality, a critical yet often overlooked dimension of surgical care. By focusing on patient-centered outcomes rather than mere physiological stability, Dr. Jang’s work has helped shift the conversation toward holistic recovery. Her findings carry significant implications for ambulatory and total intravenous anesthesia, offering clinicians a promising alternative with potential benefits in hemodynamic stability and faster emergence. Through her methodologically rigorous trials, Dr. Jang continues to shape evidence-based practice in modern anesthesiology, making her a rising voice in the pursuit of safer, more comfortable surgical experiences.
Research Focus
Key Achievements
Top Papers
- 1